The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Hent1 expression in patients with pancreatic cancer treated with gemcitabine after curative intended resection: Results from the CONKO-001 trial.
Marianne Sinn
No relevant relationships to disclose
Bruno Valentin Sinn
No relevant relationships to disclose
Jens Stieler
No relevant relationships to disclose
Uwe Pelzer
No relevant relationships to disclose
Jana Kaethe Striefler
No relevant relationships to disclose
Helmut Oettle
No relevant relationships to disclose
Marcus Bahra
No relevant relationships to disclose
Bernd Dörken
No relevant relationships to disclose
Carsten Denkert
No relevant relationships to disclose
Hendrik Blaeker
No relevant relationships to disclose
Hanno Riess
No relevant relationships to disclose
Philipp Lohneis
No relevant relationships to disclose